Alessandro Parodi
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Transplantation top 2%
Papers in
- Biomaterials 24
- Nanoparticle-Based Drug Delivery 24
-
- Protease and Inhibitor Mechanisms 10
- Co-authors
- Ennio TasciottiClaudia CorboRoberto MolinaroMichael EvangelopoulosJonathan O. MartinezNaama E. Toledano FurmanIman K. YazdiFrancesco Salvatore
- Journals
- International Journal of Molecular Sciences (9 papers)Pharmaceutics (8 papers)American Journal of Hypertension (6 papers)Scientific Reports (3 papers)ACS Nano (3 papers)
- Partner nations
- ItalyRussiaUnited States
In The Last Decade
Alessandro Parodi
100 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Biomaterials 1.6k
- Transplantation 126
- Biomedical Engineering 1.8k
- Molecular Biology 1.9k
- Pharmaceutical Science 170
Countries citing papers authored by Alessandro Parodi
This map shows the geographic impact of Alessandro Parodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Parodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Parodi more than expected).
Fields of papers citing papers by Alessandro Parodi
This network shows the impact of papers produced by Alessandro Parodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Parodi. The network helps show where Alessandro Parodi may publish in the future.
Co-authors
The 25 scholars most cited alongside Alessandro Parodi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 12 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 12 | |
| 8 | 2024 | 5 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 9 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 19 | |
| 15 | 2020 | 26 | |
| 16 | 2020 | 18 | |
| 17 | 2018 | 11 | |
| 18 | Corrosion Resistance of Cr (III) Based Conversion Layer on Zinc Coatings in Comparison with a Traditional Cr (VI) Based Passivation Treatment | 2013 | 1 |
| 19 | 2009 | 12 | |
| 20 | 2008 | 130 |
About Alessandro Parodi
Alessandro Parodi is a scholar working on Biomaterials, Cancer Research, Biomedical Engineering, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 109 papers that have together received 4.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (19 papers), Nanoplatforms for cancer theranostics (15 papers), Extracellular vesicles in disease (13 papers), Protease and Inhibitor Mechanisms (10 papers), Nanoparticles: synthesis and applications (8 papers), Graphene and Nanomaterials Applications (8 papers) and Neonatal and fetal brain pathology (7 papers). The work is most often cited by research in Biomaterials (1.6k citations), Transplantation (126 citations), Biomedical Engineering (1.8k citations), Molecular Biology (1.9k citations) and Pharmaceutical Science (170 citations). Alessandro Parodi has collaborated with scholars based in Italy, Russia and United States. Frequent co-authors include Ennio Tasciotti, Claudia Corbo, Roberto Molinaro, Michael Evangelopoulos, Jonathan O. Martinez, Naama E. Toledano Furman, Iman K. Yazdi, Francesco Salvatore, Andrey A. Zamyatnin and Brandon Brown. Their work appears in journals such as International Journal of Molecular Sciences, Pharmaceutics, American Journal of Hypertension, Scientific Reports and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.